Seroprevalence and risk factors of hepatitis delta virus in chronic hepatitis B virus infection in Zahedan

Acta Medica Iranica

Volumn 51, Issue 4, 2013, Pages 260-264

  Bakhshipour, Alireza ^a   Mashhadi, Mohammadali ^a   Mohammadi, Mahdi ^b   Nezam, Seyed Kazem ^a  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carrier; Cirrhosis; HBV; HDV; Iran; Prevalence

Indexed keywords

HEPATITIS ANTIBODY;

ADULT; ARTICLE; CHRONIC ACTIVE HEPATITIS; CROSS-SECTIONAL STUDY; DELTA AGENT HEPATITIS; DEMOGRAPHY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS DELTA VIRUS; HUMAN; IMMUNOLOGICAL TOLERANCE; INTERVIEW; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RISK FACTOR; SEROPREVALENCE; COHORT ANALYSIS; EPIDEMIOLOGY; IRAN; MIDDLE AGED; MIXED INFECTION; SOCIOECONOMICS;

ADULT; COHORT STUDIES; COINFECTION; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; IRAN; MALE; MIDDLE AGED; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS;

EID: 84883137600     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Husa P, Linhartova A, Nemecek V, Husova L. Hepatitis D. Acta Virol. 2005;49(4):219-25.
2. Govindarajan S, Chin KP, Redeker AG, Peters RL. Fulminant B viral hepatitis: role of delta agent. Gastroenterology. 1984;86(6):1417-20.
3. Rizzetto M, Canese MG, Aricò S, Crivelli O, Trepo C, Bonino F, Verme G. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977;18(12):997-1003.
4. Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet 2011Apr19.
5. Celen MK, Ayaz C, Hosoglu S, Geyik MF, Ulug M. Antihepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey. Saudi Med J 2006; Vol. 27 (5): 617-620
6. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Lankarani KB. Hepatitis B Virus Infection in Iran: A Systematic Review. Hepat Mon. 2008;8(4):281-94.
7. Karimi A, Amini S, Amirkhani A. Investigation and Comparison of hepatitis D prevalence in dialysis patients and the donors of HBsAg carrier. Teb va Tazkieh. 2000;36:30-5. Persian.
8. Zahedi MJ. Serologic Prevalence of Hepatitis D in HBsAg positive patients in Kerman, South of Iran, 2002-2003. Kerman University of Medical Sciences and Health Services. Document No 81/55; 2003. Persian.
9. Foroutan H, Nemati A, Nasiri-Tosi M, Ghofrani H, Keivani H. Prevalence of hepatitis delta virus infection in various groups with HBVinfection in Tehran, Imam Khomeini Hospital (2005-2006). Medical Journal of the Islamic Republic of Iran. 2008: 22(2):93-97.
10. Amini N, Alavian SM, Kabir A, Saiedi Hosseini SY, Aalaei-Andabili SH. Clinical Features and Seroepidemiology of Anti-HDV Antibody in patients With Chronic Hepatitis B Virus Infection in Iran: A Meta-Analysis. Hepat Mon. 2011; 11(12): 960-7.
11. Taghavi S, Sedighi S, Mehrabani D, Khademolhosseini F. Hepatitis D in chronic active hepatitis B: prevalence, liver enzymes and histopathology-an epidemiological study in Shiraz, southern Iran, 2003-2004. Hepat Mon. 2008;4(8):248-51.
12. Montazeri G, Rahban M, Mohamadnejad M, Zamani F, Hooshyar A, Fazlolahi A, Abedian S, Ghoujeghi F, Estakhri A, Montazeri F, Razjoyan H, Mamarabadi M, Alimohamadi M, Tavangar SM, Malekzadeh R. Liver histology and HBV DNA levels in chronically HBV infected patients with persistently normal alanine aminotransferase. Arch of Iranian Med, 2010; 13(3): 193-202.
13. Seifi SJ, Sabouri Ghannad M. A Study of HDV in HBsAg Positive Patients in Tabriz Northwestern Iran. Hepat Mon 2010; 10(2): 110-115.
14. Torabi S, Ebrahim-Poor S, Maljaie H, Naqili B. Seroepidemiologic study on hepatitis delta virus among HBsAg positive subjects in Tabriz, Iran. Urmia Med J. 2002;13:290-7. Persian.
15. Hassanjani-Roshan MR, Taheri H. Frequency of Chronic Active Hepatitis in Asymptomatic HBV Carriers in Babol, Iran. Arch Iranian Med. 2002;5(2):90-100.
16. Ataei B, Yazdani MR, Kalantari H, Yaran M, Nokhodian Z, Javadi AA, Babak A, Adibi P. HDV infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases. Hepat Mon. 2011;11(4): 269-72.
17. Roshandel G, Semnani S, Abdolahi N, Besharat S, Keshtkar AA, Joshaqani H, Moradi A, Kalavi K, Jabbari A, Kabir MJ, Hosseini SA, Sedaqat SM, Danesh A, Roshandel D, Hedayat-Mofidi SM. Prevalence of hepatitis D virus infection in hepatitis B surface antigen-positive subjects in Golestan province, northeast Iran. J Microbiol Immunol Infect. 2008;41(3):227-30.
18. Mohammad Alizadeh AH, Ranjbar M, Tehrani AS, Keramat F, Mamani M, Rezazadeh M, Aini P, Khalilian A, Majlesi A, Hajilooi M. Seroprevalence of Hepatitis D Virus and its Risk Factors in the West of Iran. J Microbiol Immunol Infect 2010;43(6):519-523.
19. Hajiani E, Hashemi SJ, Jalali F. Seroprevalence of Delta Hepatitis in Patients with Chronic Hepatitis B and its Clinical Impact in Khuzestan Province, Southwest Iran. Hepat Mon. 2009;9(4): 287-292.
20. Salehi M, Sanei-Moghaddam S, Khosravi S. Seroepidemiological study of HBVand HCV infection in the total population of Zahedan region, Iran. Tabib-EShargh 2005;1;63-69. Persian.
21. Sharifi-Mood B, Eshghi P, Sanei-Moghaddam E, Hashemi M. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran. Saudi Med J 2007;28:1516-9.
22. Genné D, Rossi I. Hepatitis delta in Switzerland: a silent epidemic. Swiss Med Wkly. 2011;141:w13176.
23. Sakugawa H, Nakasone H, Shokita H, Kawakami Y, Nakachi N, Adaniya H, Mizushima T, Nakayoshi T, Kinjo F, Saito A, Taira M, Takaesu H, Onga N. Seroepidemiological study on hepatitis delta virus infection in the Irabu Islands, Okinawa, Japan. J Gastroenterol Hepatol. 1997;12(4):299-304.
24. Voiculescu M, Iliescu L, Ionescu C, Micu L, Ismail G, Zilisteanu D, Radasan A, Micu G, Pertache I. A Cross-Sectional Epidemiological Study of HBV, HCV, HDV and HEV Prevalence in the SubCarpathian and South-Eastern Regions of Romania. J Gastrointestin Liver Dis 2010; 19 (1): 43-48.
25. Mumtaz K, Hamid SS, Adil S, Afaq A, Islam M, Abid S, Shah HA, Jafri W. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol. 2005;20(10):1503-7.
26. Seetlani NK, Abbas Z, Raza S, Yakoob J, Jafri W. Prevalence of Hepatitis D in HBsAg positive patients visiting liver clinics. J Pak Med Assoc. 2009; 59:434-437.
27. Sagnelli E, Stroffolini T, Ascione A, Chiaramonte M, Craxi A, Giusti G, et al. Decrease in HDV endemicity in Italy. J Hepatol 1997;26:20-4.
28. Gaete Gb, Stornaiuolo G, Precone DF. Type B and D viral hepatitis: epidiomological changes in Southern Europe. Forum (Genova). 2001;11(2):126-33.